SMI
11.791,91
PKT
-135,20
PKT
-1,13
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
03.11.11 | Zurich Insurance neutral | Exane-BNP Paribas SA | |
03.11.11 | UBS buy | Citigroup Corp. | |
03.11.11 | Geberit neutral | Citigroup Corp. | |
03.11.11 | UBS overweight | J.P. Morgan Cazenove | |
03.11.11 | Geberit buy | Vontobel Research | |
03.11.11 | UBS neutral | Nomura | |
03.11.11 | Zurich Insurance buy | Vontobel Research | |
03.11.11 | Sika buy | Vontobel Research | |
03.11.11 | Novartis buy | Deutsche Bank AG | |
03.11.11 | UBS halten | Independent Research GmbH | |
02.11.11 | Swisscom hold | UniCredit Research | |
02.11.11 | UBS sell | Société Générale Group S.A. (SG) | |
02.11.11 | Sika buy | Vontobel Research | |
02.11.11 | Holcim hold | Vontobel Research | |
02.11.11 | UBS hold | Vontobel Research | |
01.11.11 | ABB (Asea Brown Boveri) halten | Independent Research GmbH | |
31.10.11 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse AG (Haspa) | |
31.10.11 | Nestlé kaufen | Raiffeisen Centrobank AG | |
31.10.11 | Swiss Re buy | Vontobel Research | |
28.10.11 | ABB (Asea Brown Boveri) overweight | J.P. Morgan Cazenove | |
28.10.11 | Zurich Insurance buy | Deutsche Bank AG | |
28.10.11 | Holcim neutral | Citigroup Corp. | |
28.10.11 | Lonza neutral | Citigroup Corp. | |
28.10.11 | Logitech sell | Citigroup Corp. | |
28.10.11 | Novartis neutral | Goldman Sachs Group Inc. | |
28.10.11 | Lonza hold | Vontobel Research | |
28.10.11 | Logitech buy | Vontobel Research | |
28.10.11 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
28.10.11 | ABB (Asea Brown Boveri) sell | UniCredit Research | |
27.10.11 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
27.10.11 | Swisscom buy | Société Générale Group S.A. (SG) | |
27.10.11 | Novartis buy | Nomura | |
27.10.11 | Logitech buy | Vontobel Research | |
27.10.11 | UBS verkaufen | Independent Research GmbH | |
27.10.11 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
27.10.11 | Novartis buy | Citigroup Corp. | |
26.10.11 | Novartis outperform | Credit Suisse Group | |
26.10.11 | Novartis neutral | Exane-BNP Paribas SA | |
26.10.11 | Novartis halten | Independent Research GmbH | |
26.10.11 | UBS buy | Nomura |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.